Table 1 Baseline demographic characteristics
|  | Reduced LVEF group (n = 48) | Normal LVEF group (n = 253) | P value |
|---|---|---|---|
Clinical characteristics | Â | Â | Â |
Age, years | 63.69 ± 8.10 | 63.03 ± 9.60 | 0.676 |
Male, n (%) | 42 (87.5%) | 197 (77.9%) | 0.130 |
Hypertension, n (%) | 31 (64.6%) | 171 (67.6%) | 0.684 |
Diabetes, n (%) | 24 (50.0%) | 77 (30.4%) | 0.008 |
Prediabetes, n (%) | 0 (0.00%) | 7 (2.8%) | 0.520 |
Normoglycaemic, n (%) | 24 (50.0%) | 169 (66.8%) | 0.026 |
Renal insufficiency, n (%) | 3 (6.3%) | 9 (3.6%) | 0.637 |
Current or previous smoker, n (%) | 32 (66.7%) | 139 (54.9%) | 0.133 |
Previous myocardial infarction, n (%) | 9 (18.8%) | 27 (10.7%) | 0.114 |
Previous PCI, n (%) | 12 (25.0%) | 51 (20.2%) | 0.450 |
Disease types | Â | Â | Â |
Stable angina, n (%) | 2 (4.2%) | 31 (12.3%) | 0.100 |
Unstable angina, n (%) | 14 (29.2%) | 172 (68.0%) |  < 0.001 |
Post-NSTEMI (≥ 72 h), n (%) | 15 (31.3%) | 25 (9.9%) |  < 0.001 |
Post-STEMI (≥ 72 h), n (%) | 17 (35.4%) | 25 (9.9%) |  < 0.001 |
Laboratory indexes | Â | Â | Â |
Glucose level at admission, mmol/L | 6.70 (3.14) | 5.54 (1.64) | 0.001 |
Blood LDL level at admission, mmol/L | 2.92 ± 0.91 | 2.74 ± 0.93 | 0.169 |
NT-proBNP, pg/mL | 819.50 (1412) | 109.00 (220) |  < 0.001 |
Troponin I, ug/L | 5.36 ± 10.81 | 1.86 ± 7.93 |  < 0.001 |
CRP, mg/L | 5.23 (8.94) | 1.69 (4.51) |  < 0.001 |
Interrogated vessel | Â | Â | Â |
Left anterior descending branch, n (%) | 26 (54.2%) | 146 (57.7%) | 0.649 |
Circumflex branch, n (%) | 7 (14.6%) | 49 (19.4%) | 0.435 |
Right coronary artery, n (%) | 15 (31.3%) | 58 (22.9%) | 0.217 |